Cargando…

Exploring specific prognostic biomarkers in triple-negative breast cancer

Lacking of both prognostic biomarkers and therapeutic targets, triple-negative breast cancer (TNBC) underscores pivotal needs to uncover novel biomarkers and viable therapies. MicroRNAs have broad biological functions in cancers and may serve as ideal biomarkers. In this study, by data mining of the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bao, Chang, Lu, Yunkun, Chen, Jishun, Chen, Danni, Lou, Weiyang, Ding, Bisha, Xu, Liang, Fan, Weimin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6813359/ https://www.ncbi.nlm.nih.gov/pubmed/31649243 http://dx.doi.org/10.1038/s41419-019-2043-x

Ejemplares similares

MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1
por: Bao, Chang, et al.
Publicado: (2020)

High Expression of Pseudogene PTTG3P Indicates a Poor Prognosis in Human Breast Cancer
por: Lou, Weiyang, et al.
Publicado: (2019)

Overexpressed pseudogenes, DUXAP8 and DUXAP9, promote growth of renal cell carcinoma and serve as unfavorable prognostic biomarkers
por: Chen, Jing, et al.
Publicado: (2019)

Identification of chemoresistance-associated miRNAs in breast cancer
por: Lou, Weiyang, et al.
Publicado: (2018)

hsa_circ_0001955 Enhances In Vitro Proliferation, Migration, and Invasion of HCC Cells through miR-145-5p/NRAS Axis
por: Ding, Bisha, et al.
Publicado: (2020)

In silico analysis excavates potential biomarkers by constructing miRNA-mRNA networks between non-cirrhotic HCC and cirrhotic HCC
por: Ding, Bisha, et al.
Publicado: (2019)

Overexpression of GPX3, a potential biomarker for diagnosis and prognosis of breast cancer, inhibits progression of breast cancer cells in vitro
por: Lou, Weiyang, et al.
Publicado: (2020)

A novel mRNA-miRNA-lncRNA competing endogenous RNA triple sub-network associated with prognosis of pancreatic cancer
por: Wang, Wenlong, et al.
Publicado: (2019)

Identification of invasion-metastasis-associated microRNAs in hepatocellular carcinoma based on bioinformatic analysis and experimental validation
por: Lou, Weiyang, et al.
Publicado: (2018)

Non-coding RNA in drug resistance of hepatocellular carcinoma
por: Ding, Bisha, et al.
Publicado: (2018)

Construction of Potential Glioblastoma Multiforme-Related miRNA-mRNA Regulatory Network
por: Lou, Weiyang, et al.
Publicado: (2019)

Whole-transcriptome analysis reveals a potential hsa_circ_0001955/hsa_circ_0000977-mediated miRNA-mRNA regulatory sub-network in colorectal cancer
por: Ding, Bisha, et al.
Publicado: (2020)

CASK Silence Overcomes Sorafenib Resistance of Hepatocellular Carcinoma Through Activating Apoptosis and Autophagic Cell Death
por: Ding, Bisha, et al.
Publicado: (2021)

RP11-480I12.5-004 Promotes Growth and Tumorigenesis of Breast Cancer by Relieving miR-29c-3p-Mediated AKT3 and CDK6 Degradation
por: Lou, Weiyang, et al.
Publicado: (2020)

Identification of potential miRNA–mRNA regulatory network contributing to pathogenesis of HBV-related HCC
por: Lou, Weiyang, et al.
Publicado: (2019)

A novel antimicrobial polymer efficiently treats multidrug-resistant MRSA-induced bloodstream infection
por: Chen, Xu, et al.
Publicado: (2019)

Five miRNAs-mediated PIEZO2 downregulation, accompanied with activation of Hedgehog signaling pathway, predicts poor prognosis of breast cancer
por: Lou, Weiyang, et al.
Publicado: (2019)

microRNA-Dependent Modulation of Genes Contributes to ESR1's Effect on ERα Positive Breast Cancer
por: Gao, Shan, et al.
Publicado: (2020)

MicroRNAs in cancer metastasis and angiogenesis
por: Lou, Weiyang, et al.
Publicado: (2017)

Construction of an mRNA-miRNA-lncRNA network prognostic for triple-negative breast cancer
por: Huang, Yuan, et al.
Publicado: (2021)

Identification of key genes as potential biomarkers for triple-negative breast cancer using integrating genomics analysis
por: Zhong, Guansheng, et al.
Publicado: (2020)

Dysregulation of pseudogene/lncRNA-hsa-miR-363-3p-SPOCK2 pathway fuels stage progression of ovarian cancer
por: Lou, Weiyang, et al.
Publicado: (2019)

Pseudogene-Derived lncRNAs and Their miRNA Sponging Mechanism in Human Cancer
por: Lou, Weiyang, et al.
Publicado: (2020)

Development of an immune-related prognostic biomarker for triple-negative breast cancer
por: Zhang, Yan, et al.
Publicado: (2022)

Endocan as a prognostic biomarker of triple-negative breast cancer
por: Sagara, Atsunobu, et al.
Publicado: (2016)

Distinct expression pattern and prognostic values of pituitary tumor transforming gene family genes in non-small cell lung cancer
por: Yang, Shaolong, et al.
Publicado: (2019)

RUNX2: a prognostic biomarker for triple-negative breast cancer?
Publicado: (2014)

Triple-negative breast cancer: promising prognostic biomarkers currently in development
por: Sukumar, Jasmine, et al.
Publicado: (2021)

Promoter Hypomethylation and miR-145-5p Downregulation- Mediated HDAC11 Overexpression Promotes Sorafenib Resistance and Metastasis of Hepatocellular Carcinoma Cells
por: Wang, Wenlong, et al.
Publicado: (2020)

The Involvement of the hsa_circ_0088494-miR-876-3p-CTNNB1/CCND1 Axis in Carcinogenesis and Progression of Papillary Thyroid Carcinoma
por: Lou, Weiyang, et al.
Publicado: (2020)

Highly heterogeneous-related genes of triple-negative breast cancer: potential diagnostic and prognostic biomarkers
por: Liu, Yiduo, et al.
Publicado: (2021)

Efficacy and prognostic factors of neoadjuvant chemotherapy for triple-negative breast cancer
por: Ding, Feng, et al.
Publicado: (2022)

TTK is a favorable prognostic biomarker for triple-negative breast cancer survival
por: Xu, Qianqian, et al.
Publicado: (2016)

Prognostic Effect of Microenvironment Phenotype in Triple-Negative Breast Cancer: Biomarker Analysis of a Prospective Trial
por: Zhu, Si-Yuan, et al.
Publicado: (2021)

SENP3 promotes tumor progression and is a novel prognostic biomarker in triple-negative breast cancer
por: Zhu, Youzhi, et al.
Publicado: (2023)

CD8 T Cell Score as a Prognostic Biomarker for Triple Negative Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

ITPKC as a Prognostic and Predictive Biomarker of Neoadjuvant Chemotherapy for Triple Negative Breast Cancer
por: Oshi, Masanori, et al.
Publicado: (2020)

CCR5 is a prognostic biomarker and an immune regulator for triple negative breast cancer
por: Wang, Xin, et al.
Publicado: (2021)

Genome Instability-Derived Genes Are Novel Prognostic Biomarkers for Triple-Negative Breast Cancer
por: Guo, Maoni, et al.
Publicado: (2021)

Impact of central obesity on prognostic outcome of triple negative breast cancer in Chinese women
por: Chen, Hong-liang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_eihtneei3vmdkkj0rv9vp15f7v